900912:SSEShanghai Waigaoqiao Free Trade Zone Group Co., Ltd. Class B Analysis
Data as of 2026-07-21 - not real-time
$0.62
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Shanghai Waigaoqiao Free Trade Zone Group is trading at 0.619 USD, barely above its computed support level of 0.61, while the 20‑day SMA (0.651) sits below both the 50‑day (0.657) and 200‑day (0.687) averages, confirming a bearish price structure. The RSI of 32 suggests the stock is oversold, yet the MACD histogram remains negative and the signal line is bearish, indicating limited upside momentum. Fundamentals show a strikingly low PE ratio of 6.19 versus an industry average of over 30, and a PB of 0.36, positioning the stock as a deep‑value play with an attractive dividend yield of 8.36%. However, the balance sheet is heavily weighted toward debt, with a debt‑to‑equity of 147% and a massive negative free cash flow of roughly -3.7 billion USD, raising concerns about dividend sustainability and financial flexibility.
The 30‑day volatility of nearly 29% combined with a very low beta (~0.12) points to price swings that are largely idiosyncratic rather than market‑driven. Liquidity appears adequate given average daily volumes, but the company’s exposure to Chinese regulatory and policy shifts in the free‑trade zone sector adds a layer of uncertainty. In the short run, price pressure near support and bearish technical signals suggest further downside risk; medium‑term prospects are muted as earnings growth stalls and debt remains high; the long‑term thesis hinges on potential debt restructuring and the ability to maintain the generous dividend while improving cash generation.
The 30‑day volatility of nearly 29% combined with a very low beta (~0.12) points to price swings that are largely idiosyncratic rather than market‑driven. Liquidity appears adequate given average daily volumes, but the company’s exposure to Chinese regulatory and policy shifts in the free‑trade zone sector adds a layer of uncertainty. In the short run, price pressure near support and bearish technical signals suggest further downside risk; medium‑term prospects are muted as earnings growth stalls and debt remains high; the long‑term thesis hinges on potential debt restructuring and the ability to maintain the generous dividend while improving cash generation.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price hovering just above technical support
- Bearish MACD and downward SMA hierarchy
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Deep value multiples (PE, PB) versus peers
- Attractive dividend yield but debt burden
- Stagnant revenue growth and negative free cash flow
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount to industry
- Potential for debt restructuring or refinancing
- Sustained high dividend yield if cash generation improves
Key Metrics & Analysis
Financial Health
Revenue Growth-0.50%
Profit Margin15.25%
P/E Ratio6.2
ROE6.15%
ROA0.90%
Debt/Equity147.37
P/B Ratio0.4
Op. Cash Flow$434.6M
Free Cash Flow$-3673059584
Industry P/E30.6
Technical Analysis
TrendBearish
RSI32.8
Support$0.61
Resistance$0.69
MA 20$0.65
MA 50$0.66
MA 200$0.69
MACDBearish
VolumeStable
Fear & Greed Index90.07
Valuation
GradeUndervalued
TypeValue
Dividend Yield8.36%
Risk Assessment
Beta0.12
Volatility28.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.